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The haemopoietic system, in which proliferation
and commitment to differentiation along at least
five distinct pathways continues throughout life,
provides an ideal cell system for studying
mechanisms which direct cells to differentiate into
one type or another. An insight into this problem is
clearly important if we are to understand the
population structure, kinetics and regulation of
complex, heterogeneous cell populations such as the
haemopoietic system. An understanding of these
problems will be essential to resolve the problem of
haemopoietic cell transformation which may often
involve progenitor cells (Lajtha, 1979).
As yet, it is not clear how pluripotent
haemopoietic stem cells give rise to monopotent
progenitor cells. Ogawa and colleagues argue from
their studies of oligopotent progenitor cells in
culture that the restriction in differentiation poten-
tials of stem cells is a progressive and stochastic
process (Nakahata & Ogawa, 1982; Ogawa et al.,
1983; Suda et al., 1984). Alternatively, Nicola and
Johnson (1982) interpret their studies of committed
progenitor cells to suggest 'a defined sequence of
successive restriction of potentials'. In this case the
pluripotent stem cells progressively loses differen-
tiation options until only the capacity to differen-
tiate along the erythroid lineage remains. We
would like to consider a further model for stem
cell commitment which hypothesizes that lineage
potentials are consecutively and individually
expressed in a defined sequence as progenitor cells
mature. This possibility can be revealed from
studies of variant lines derived from the promyeloid
cell line HL60 described below.
HL60 cells are at a stage of maturation at which
they are still able to differentiate into either
neutrophils (Collins et al., 1978) or monocytes
(Rovera et al., 1979) when treated with appropriate
inducers. The bipotential nature of these cells
provides a model system in which processes which
restrict the differentiation of cells to a particular
lineage can be studied. One useful approach to this
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problem is to derive variant sub-lines from HL60
cultures which show restricted abilities to mature
towards either neutrophils and/or monocytes. We,
together with other investigators, have described a
number of variant HL60 lines (Bodner et al., 1980;
Major et al., 1981; Fisher et al., 1982; Huberman et
al., 1982; Toksoz et al., 1982; Bunce et al., 1983;
Kuribayaski et al., 1983). In our own studies stable
sub-lines were isolated in medium containing 1.25%
dimethylsulphoxide (DMSO) which optimally
induces HL60 cells to differentiate into neutrophils.
Cells of some, but not all of the sub-lines, fail to
differentiate into monocytes when treated with
either 12-0-tetradecanoylphorbol-13-acetate (TPA)
or a factor used to induce monocyte differentiation
(Bunce et al., 1983; & unpublished observations).
These spontaneously arising variant lines may
represent subpopulations of cells within the
parental HL60 culture with various inherent
capacities for neutrophil and monocyte differen-
tiation. The utility of these sub-lines lies in their
contribution to our understanding of precisely how
the variant cell populations relate to the parental
cells and to each other. Do these lines represent
cells at different stages of differentiation with
respect to their ability to differentiate and their
phenotypic characteristics?
An interesting correlation has been observed
between the expression of two myeloid-associated
antigens (AGF 4.36, AGF 4.48) and the ability of
variant HL60 lines to differentiate towards mono-
cytes. The variant lines which are unable to
differentiate into monocytes express both myeloid
antigens to the same extent as HL60. Conversely,
lines able to mature towards monocytes fail to
express these antigens (Bunce et al., 1983). Both
AGF 4.36 and AGF 4.48 antigens are lost as HL60
cells are induced to mature towards monocytes but
only AGF 4.36 is lost during neutrophil dif-
ferentiation (Fisher et al., 1982; & see Figure 1).
How can we now interpret both the inducibility of
the variant cell lines and their expression of these
myeloid antigens to give a cohesive picture of HL60
differentiation?
Collective data from our own studies of variant
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Figure 1 A model for HL60 cell differentiation. Variant cell lines derived from HL60 are arranged in a
proposed developmental sequence as regards their responsiveness to inducer of neutrophil and monocyte
differentiation and the pattern ofmyeloid antigen expression by these lines.
HL60 lines (Toksoz et al., 1982; Bunce et al., 1983)
and antigen expression during neutrophil and
monocyte differentiation (Fisher et al., 1982) are
used to propose the model for HL60 differentiation
shown in Figure 1. We assume in this figure that
the variant sub-lines reflect an inherent hetero-
geneous responsiveness of HL60 cells to inducers
of neutrophil and monocyte differentiation. The
variant lines are arranged in a sequence of develop-
ment which proposes that cells within HL60 cultures
first acquire a capacity for differentiation induction
into neutrophils; later they are able to differentiate
into either neutrophils or monocytes and finally can
only be directed towards monocyte differentiation.
As observed experimentally, this inherent develop-
mental progression does not continue spontaneously
to give rise to large numbers of terminally
differentiated cells. The culture habitat in some way
attains a steady-state balance covering a range of
potential for both neutrophil and monocyte
differentiation. The variant lines HL60 Ast 3, Ast 4
and Spl mostly represent cells within the parental
HL60 culture which have not yet undergone a
differentiation step necessary for acquisition of the
ability to respond to induction signals for monocyte
differentiation. These lines are unresponsive to a
wide range of concentrations of inducers of mono-
cyte differentiation. The HL60 Ast 3, Ast 4 and Spl
lines fail to respond to TPA concentrations in the
range 4-50nM as compared with 4nm TPA
required to induce HL60 monocyte differentiation
(Bunce et al., 1983). Similarly, conditioned medium
containing a factor which induces monocyte differ-
entiation is used at a concentration of 2.5% to
induce HL60 differentiation and the HL60 Ast 3,
Ast 4 and Spl lines respond minimally to concentra-
tions of medium of up to 10% (unpublished
observations). The variant lines HL6Om2, m4, Ast
25 and Ast 1 have properties which indicate they
are past the differentiation step at which cells are
optimally bipotential. Figure 1 shows there is first a
progressive acquisition of capacity to be induced to
neutrophil differentiation within cells in HL60
cultures followed by a progressive loss of this
capacity as cells are subsequently restricted to
monocyte differentiation. It is proposed that the
variant lines which require higher concentrations of
DMSO than the parental line to be induced to
differentiate towards neutrophils reflect earlier and
later phases of maturation. Neutrophil dif-
ferentiation is induced in HL60 cultures by 1.25%
DMSO. HL6Om2, m4, Ast 3 and Spl can be
induced to mature into neutrophils using 1.75%
DMSO, HL60 Ast 25 cells require 2.0% DMSO
and HL60 Ast 1 and Ast 4 cultures show minimal
neutrophil differentiation at a concentration of
2.0% DMSO.
The picture which emerges is that the HL60 and
variant cells populations as a whole maintain
different steady-states as regards the distribution of
cells at various stages of commitment to neutrophil
and/or monocyte differentiation. An indication that
a shift in the distribution of committed cells and
hence differentiation status has occurred in the
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variant cell cultures is shown by the following
observation. The HL6Om2 and m4 lines are shown
in Figure 1 to be more mature than HL60 cells with
respect to their progress towards monocyte dif-
ferentiation. These cell lines show to a minor degree
some spontaneous differentiation into monocytes
even when cultured routinely in 1.25% DMSO.
Occasional alpha-napthylbutyrate esterase positive
cells are routinely seen in HL6Om2 and m4 cultures.
These are not observed in HL60 cultures.
If the variant cell lines are arranged in the
proposed developmental sequence the pattern of
myeloid antigen expression by these lines is found
to correlate with antigen expression when HL60 is
induced to differentiate to neutrophils or
monocytes. Both myeloid antigens, AGF 4.36 and
AGF 4.48, which are lost during monocyte dif-
ferentiation are not expressed by the variant cell
lines which to some extent are more inclined
towards monocyte differentiation. Variant lines
showing a reduced ability for neutrophil dif-
ferentiation, but at a stage prior to acquiring the
potential for monocyte differentiation, express both
antigens one of which is retained throughout
neutrophil differentiation. It is interesting to look at
expression of the AGF 4.48 antigen, which is
normally retained throughout HL60 neutrophil
differentiation, as the HL6Om2 and m4 cells mature
towards neutrophils when treated with 1.75%
DMSO. If these lines are correctly placed in the
developmental sequence and are at a stage of
having lost the AGF 4.48 antigen (rather than at a
stage prior to expressing this antigen) and the
developmental program is irreversible then HL6Om2
and m4 cells should mature into neutrophils
without expressing the AGF 4.48 antigen. Neither
the AGF 4.48 nor the AGF 4.36 antigen is
expressed as HL6Om2 and m4 cells mature into
neutrophils (Bunce et al., 1983).
Cells within the HL60 population show the same
sequence of acquisition of neutrophil and monocyte
differentiation capacity as proposed during normal
myelopoiesis. Studies of Dexter and colleagues have
shown that normal progenitor cells first acquire the
capacity to be induced to terminally differentiate to
neutrophils and subsequently acquire responsiveness
to inducers of monocyte differentiation. Thus, the
proposed sequence of development of committed
progenitor cells during normal neutrophil and
macrophage differentiation is granulocyte-colony
formingcell(CFC)- granulocyte/macrophage-CFC--
macrophage-CFC (Dexter et al., 1980). It is
interesting to speculate whether a progressive
acquisition and restriction to neutrophil develop-
ment followed by loss of this potential as progenitor
cells are restricted to monocyte differentiation
occurs only in relation to granulocyte/macrophage
progenitor cells or reveals a fundamental principle
during haemopoiesis. This sequential process of
stem cell commitment is contrary to the 'stochastic'
model of Ogawa et al. (1983) and 'successive
restriction' model of Nicola and Johnson (Nicola &
Johnson, 1982).
In Figure 2 we propose that as pluripotent stem
cells are committed to differentiation their future
possible goals are individually and sequentially
expressed in an order determined inherently within
the genome. Cells within the sequence shown are
precommitted as regards their ability to respond to
various inducers of differentiation and on en-
countering an appropriate factor(s) or suitable
microenvironment undergo proliferation and
maturation along a particular pathway. Progenitor
cells which do not receive a signal for differen-
tiation towards mature end cells progress onto the
next stages in the sequence of development.
Commitment is gradual so that the progenitor cells
are a continuous spectrum of cells. Therefore cells
may be at a developmental stage of being able to
respond, for example, to either inducers of neutro-
phil or monocyte differentiation, as is the case of
HL60 cells. In terms of renewal of progenitor cell
populations, cells continuously occupy each potential
for differentiation at any given time and therefore
respond to the requirement for each mature cell
type. The continuous development ofprogenitor cells
may not be diverted entirely towards, for
example, granulocyte production in the presence of
granulocyte differentiation factors for the reasons
that progenitor cells which respond, as they divide,
may generate some cells which are still able to
progress or are selected to progress to the next
stage of commitment. This decision may be
governed by a stochastic rule in view of the data of
Ogawa and colleagues (Ogawa et al., 1983; Suda et
al., 1984) and Korn and colleagues (Korn et al.,
1973).
There is no direct evidence for the order of cell
commitment shown in Figure 2. However, a num-
ber of diverse observations support the proposed
sequence. The transition from granulocyte commit-
ment to monocyte commitment has been argued
from studies of variant cell lines derived from
HL60. A close relationship between the potentials
for macrophage and B cell differentiation can be
inferred from the experiments of Boyd and
Schrader (1982). In their studies cloned
macrophage-like cell lines were derived from the
murine pre-B lymphoma ABLS8.1 after cells were
exposed to 5-azacytidine. As in the studies of HL60
described above, it is possible that the potential for
monocyte differentiation revealed by the sub-lines
represents heterogeneity within the parental cell
population. In the case of both the HL60 and684 G. BROWN et al.
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Figure 2 Proposed sequence of cell commitment during haemopoiesis. The cells diagonally to the left
represent progenitor cells committed to megakaryocyte (Me), erythroid (E), neutrophil (G), monocyte (M), B
cell (B) and T cell (T) differentiation. Differentiation towards mature end cells is indicated by -- and the
process of progenitor cell development by .
ABLS8.1 cell lines, the arguments assume that the
differentiation potentials observed within ABLS8.1
or when HL60 cells are induced to mature are
representative of the developmental relationships
which occur in normal progenitor cells. Problems
associated with aneuploidy and gene amplification
effects could argue that cultured tumour cell lines
may give misleading information. Nevertheless, it is
likely that the normal sequence of development of
lineage potentials is maintained in many tumour
cell lines.
Studies of rearrangement of immunoglobulin
heavy chain genes in the human myeloid cell line
ML-1 (Rovigatti et al., 1984), murine T cell hybrids
and T lymphomas (Zunica et al., 1982) and T cell
acute lymphoblastic leukaemia (Kitchingman et al.,
1985) support a sequence of progression from
myeloid to B cell and subsequent T-cell com-
mitment. In the case of ML-1, rearrangements in
the heavy chain region suggest that this cell line
represents transformation of a progenitor cell with
potentials for both myeloid and B cell dif-
ferentiation (Rovigatti et al., 1984). Kurosawa and
colleagues suggested from their early findings that
diversity (D) and joining (JH) segments of immuno-
globulin heavy chain genes are joined in DNA from
cloned murine cytolytic T cells that this may have
occurred in a progenitor cell which is common to
both B and T cells (Kurosawa et al., 1981).
Whether commitment to B and T cell differen-
tiation represents the last stages in the develop-
mental sequence is at present unclear. An
alternative viewpoint is that potentials for B and T
cell differentiation are expressed prior to the
sequence of megakaryocyte, erythroid and
granulocyte commitment. This is suggested by the
studies of Abramson and colleagues of radiation-
induced chromosome aberrations in progenitor cells
which proposed that B lymphocytes are derived
directly from the pluripotent stem cell (Abramson
et al., 1977).
The proposed sequence of commitment at early
stages from megakaryocyte to erythroid to neutro-
phil potentials takes into considerations the lineage
potentials of progenitor cells in culture (CFC)
which appear to be restricted to two pathways
of differentiation. Megakaryocyte/erythroid and
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described in cultures of human and murine cells
(Ogawa et al., 1983). However, in this case and also
situations where maturation along four lineages is
observed i.e. granulocyte-erthrocyte-macrophage-
megakaryocyte (GEMM) colonies, the types of
cells found in colonies in culture may depend on
the relative presence of factors which support
expression of various potentialities or progression
along the sequence of commitment. As in the model
of Nicola and Johnson (1982) commitment to
megakaryocyte and erythroid differentiation are
obligatory steps during stem cell maturation and
erythroid cells together with megakaryocytes should
always be seen in mixed colonies. Erythroid cells
are invariably seen (Johnson, 1981) and colonies
would have to be stained appropriately to show the
presence of megakaryocytes (Nicola & Johnson,
1982).
The linear progression of events during stem cell
commitment can be considered either in terms of
the sequential ability of cells to respond to various
inducers of differentiation or that there is a pre-
determined sequential rather than random re-
arrangement of various genes prerequisite for dif-
ferentiation towards a particular cell type. In this
case, for example, during B and T cell development,
the progenitor cell first rearranges immunoglobulin
heavy chain genes which is prerequisite though
insufficient for terminal B cell differentiation
(Kitchingman et al., 1985). Failure to receive a
signal required to continue development along this
pathway leads then to rearrangement of receptor
genes appropriate for T cell maturation.
The model proposed has important implications
as regards malignancy and the control of normal
haemopoiesis. At present, it is not known whether
gene rearrangement occurs in cells other than
lymphocytes which clearly rearrange genes with
respect to receptor diversity. However, progenitor
cells together with lymphocytes are often 'targets'
for cell transformation which can be explained by
suggesting that DNA rearrangement during stem
cell determination and lymphocyte differentiation
provides active sites within the genome which are
susceptible to inappropriate gene recombination
events. Hence, during normal cell commitment
patterns of gene rearrangement are conservatively
followed. Some genetic processes may be repeated if
they are useful at each stage of development, for
example, genomic events which determine at each
state of commitment to what extent cells are able to
proliferate. Leukaemias, other than those involving
mature, immunocompetent T or B cells, may be
viewed as a lesion in the progressive events during
stem cell determination. If inappropriate gene re-
arrangement occurs late in the sequence of
development of progenitor cells then this gives rise
to the acute lymphoid leukaemias. Chronic myeloid
leukaemia could be viewed as the same lesion
occurring at a very early stage in progenitor cell
development which is manifest throughout
sequential commitment of the 'transformed' clone.
The maturation sequence of progenitor cells is
pertinent to considerations of the nature of surface
molecules and factors which regulate the pro-
liferation and development of committed cells.
Cell surface molecules which are expressed
throughout the stages of commitment, for example,
class II antigens, which are present on erythroid,
myeloid and lymphoid precursor cells, may have a
functional role in controlling the proliferation or
differentiation status of cells during the process of
cell commitment (Brown et al., 1984). At the end of
the sequence shown in Figure 2 progenitor cells
committed to T cell differentiation are the last to be
generated. Torok-Storb and Hansen (1982) have
shown that T cells can enhance and limit the
growth of erythroid progenitor cells. Class II
molecules seem to be involved in the inhibiting
effect of T cells. It is interesting to speculate that T
cells may provide an important feedback control on
the rate of renewal of progenitor cells. Also, it is
important to consider whether interleukins such as
IL3 are required during sequential determination of
lineage potentials if this process involves cell
divisions.
To return to the problem of how cells mature
into one cell type or another, it is likely that the
changes occurring are gradual and progressive, as
opposed to clear on/off, events within cells. This
makes analysis a little more difficult but resolution
is possible by using populations of cells at various
stages in a particular developmental sequence. The
variant HL60 lines, in the order show in Figure 1,
essentially typify the progression of acquisition of
neutrophil and monocyte differentiation capacity.
Analysis of events which direct HL60 cells to
differentiate into one cell type or another can be
approached by looking for intrinsic patterns of
differences between the variant lines which correlate
with their relative position in the developmental
sequence.
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